Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 1
2009 2
2010 2
2011 4
2012 1
2013 3
2014 5
2015 2
2016 1
2017 1
2018 4
2019 5
2020 3
2021 10
2022 7
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

47 results

Results by year

Filters applied: . Clear all
Page 1
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial.
Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Riesmeyer JS, Riddle MC, Rydén L, Xavier D, Atisso CM, Dyal L, Hall S, Rao-Melacini P, Wong G, Avezum A, Basile J, Chung N, Conget I, Cushman WC, Franek E, Hancu N, Hanefeld M, Holt S, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Cardona Munoz EG, Pirags V, Pogosova N, Raubenheimer PJ, Shaw JE, Sheu WH, Temelkova-Kurktschiev T; REWIND Investigators. Gerstein HC, et al. Lancet. 2019 Jul 13;394(10193):121-130. doi: 10.1016/S0140-6736(19)31149-3. Epub 2019 Jun 9. Lancet. 2019. PMID: 31189511 Clinical Trial.
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial.
Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Botros FT, Riddle MC, Rydén L, Xavier D, Atisso CM, Dyal L, Hall S, Rao-Melacini P, Wong G, Avezum A, Basile J, Chung N, Conget I, Cushman WC, Franek E, Hancu N, Hanefeld M, Holt S, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Cardona Munoz EG, Pirags V, Pogosova N, Raubenheimer PJ, Shaw JE, Sheu WH, Temelkova-Kurktschiev T; REWIND Investigators. Gerstein HC, et al. Lancet. 2019 Jul 13;394(10193):131-138. doi: 10.1016/S0140-6736(19)31150-X. Epub 2019 Jun 9. Lancet. 2019. PMID: 31189509 Clinical Trial.
Pasireotide in the Personalized Treatment of Acromegaly.
Puig-Domingo M, Bernabéu I, Picó A, Biagetti B, Gil J, Alvarez-Escolá C, Jordà M, Marques-Pamies M, Soldevila B, Gálvez MA, Cámara R, Aller J, Lamas C, Marazuela M. Puig-Domingo M, et al. Among authors: soldevila b. Front Endocrinol (Lausanne). 2021 Mar 16;12:648411. doi: 10.3389/fendo.2021.648411. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 33796079 Free PMC article. Review.
[Safety and tolerability of GLP-1 receptor agonists].
Soldevila B, Puig-Domingo M. Soldevila B, et al. Med Clin (Barc). 2014;143 Suppl 2:35-40. doi: 10.1016/S0025-7753(14)70107-1. Med Clin (Barc). 2014. PMID: 25326842 Review. Spanish.
[Safety and tolerability of GLP-1 receptor agonists].
Soldevila B, Puig-Domingo M. Soldevila B, et al. Med Clin (Barc). 2014 Sep;143 Suppl 2:35-40. doi: 10.1016/S0025-7753(14)70107-1. Epub 2014 Oct 15. Med Clin (Barc). 2014. PMID: 25437464 Review. Spanish.
Regulatory T cells in diabetes and gastritis.
Alonso N, Soldevila B, Sanmartí A, Pujol-Borrell R, Martínez-Cáceres E. Alonso N, et al. Among authors: soldevila b. Autoimmun Rev. 2009 Jul;8(8):659-62. doi: 10.1016/j.autrev.2009.02.014. Epub 2009 Feb 12. Autoimmun Rev. 2009. PMID: 19393198 Review.
Longitudinal trajectories of maternal TSH in healthy pregnant women in Catalonia.
Soldevila B, Velasco I, Muñoz C, Díaz Y, Egea-Cortés L, Ferrer-Escopiñan L, Pérez-Montes de Oca A, Martínez-Mondejar R, Casabona J, Puig-Domingo M. Soldevila B, et al. Eur Thyroid J. 2023 Aug 11;12(5):e230016. doi: 10.1530/ETJ-23-0016. Eur Thyroid J. 2023. PMID: 37429330 Free PMC article.
47 results